Journal of the Korean Society of Radiology (대한영상의학회지)

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Palliative Transcatheter Arterial Chemoembolization for Relieving Metastatic Bone Pain due to Hepatocellular Carcinoma: A Case Report

간세포암에서 유래한 골전이의 통증 완화를 위한 고식적 경동맥 화학색전술: 증례 보고

  • Ryu, Hye Ji (Department of Radiology, Wonkwang University School of Medicine & Hospital) ;
  • Moon, Sung Nam (Department of Radiology, Wonkwang University School of Medicine & Hospital) ;
  • Chang, Nam Kyu (Department of Radiology, Yeonggwang Medical Center)
  • 류혜지 (원광대학교 의과대학 원광대학교병원 영상의학과) ;
  • 문성남 (원광대학교 의과대학 원광대학교병원 영상의학과) ;
  • 장남규 (영광종합병원 영상의학과)
  • Received : 2017.09.12
  • Accepted : 2018.05.22
  • Published : 2018.10.01
⟨ Previous Next ⟩

Abstract

Bone metastasis is the third most common extrahepatic metastasis from hepatocellular carcinoma (HCC), following lung and lymph node metastasis. Although transcatheter arterial chemoembolization (TACE) is widely used for the treatment for unresectable HCC in the liver, its effects on bone metastasis from HCC have not been well described in past literature. We report a case of a patient with a metastatic bone lesion from an HCC treated with TACE. After the procedure, the patient's pain and narcotic requirement significantly decreased without major complications.

골전이는 폐와 림프절 다음으로 간세포암의 3번째로 흔한 간외전이이다. 경동맥화학색전술이 절제불가능한 간내 간세포암의 치료에 널리 사용되고 있지만 간세포암의 골전이에서의 효과에 대해서는 잘 알려져 있지 않다. 이에 본 저자들은 간세포암의 골전이가 있었던 환자에서 경동맥화학색전술로 치료하였던 증례를 보고하고자 한다. 시술 후 주요 합병증 없이 환자의 통증과 마약성 진통제 필요량이 감소하였다.

Keywords

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917
  2. Fukutomi M, Yokota M, Chuman H, Harada H, Zaitsu Y, Funakoshi A, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2001;13:1083-1088
  3. Koike Y, Takizawa K, Ogawa Y, Muto A, Yoshimatsu M, Yagihashi K, et al. Transcatheter arterial chemoembolization (TACE) or embolization (TAE) for symptomatic bone metastases as a palliative treatment. Cardiovasc Intervent Radiol 2011;34:793-801
  4. Chiras J, Adem C, Vallee JN, Spelle L, Cormier E, Rose M. Selective intra-arterial chemoembolization of pelvic and spine bone metastases. Eur Radiol 2004;14:1774-1780
  5. Kato T, Nemoto R, Mori H, Takahashi M, Harada M. Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs. Cancer 1981;48:674-680
  6. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain 1997;69:1-18
  7. Stein C. Opioids, sensory systems and chronic pain. Eur J Pharmacol 2013;716:179-187
  8. Uemura A, Fujimoto H, Yasuda S, Osaka I, Goto N, Shinozaki M, et al. Transcatheter arterial embolization for bone metastases from hepatocellular carcinoma. Eur Radiol 2001;11: 1457-1462
  9. Barton PP, Waneck RE, Karnel FJ, Ritschl P, Kramer J, Lechner GL. Embolization of bone metastases. J Vasc Interv Radiol 1996;7:81-88
  10. Sun S, Lang EV. Bone metastases from renal cell carcinoma: preoperative embolization. J Vasc Interv Radiol 1998;9:263-269